ClinicalTrials.govpublic full text
Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
gastroesophageal reflux disease (gerd), gerd, ppi, heartburn, regurgitation, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1008679
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.